Market Research Reports Annoucements

Global Synthetic Biology Market 2014-2018

The Global Synthetic Biology market is expected to grow at a CAGR of 33.8 percent over the period 2013-2018.

- Advertisement - 

Global Synthetic Biology Market 2014-2018 is a new market research publication announced by Reportstack. The term synthetic biology covers the designing and engineering of completely new biological parts, devices, and organisms as well as the redesigning of natural biological systems that provide improved and desirable functions. It is considered to be a form of extreme genetic engineering because it not only alters existing metabolic pathways, but also creates new ones. The engineered biological systems can be used to manipulate chemicals, fabricate materials and structures, produce energy, provide GM food, improve the efficiency of drugs and vaccines, and maintain a sustainable environment.


The analysts forecast that the Global Synthetic Biology market will grow at a CAGR of 33.8 percent over the period 2013-2018. The Global Synthetic Biology market can be categorized on the basis of technology into four segments: Genome Engineering. DNA Sequencing, Bioinformatics, and Biological Components and Integrated Systems. 

The report Global Synthetic Biology Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Synthetic Biology market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

- Advertisement - 

Key Regions
• Americas 
• EMEA 
• APAC

Key Vendors
• Amyris Inc.
• E. I. du Pont de Nemours and Co. 
• Thermo Fisher Scientific Inc. 
• Synthetic Genomics Inc.

Other Prominent Vendors
• Algenol Biofuels Inc.
• ATG:biosynthetics GmbH
• Bayer AG
• Bioneer Corp. 
• Biosearch Technologies Inc.
• Bristol-Myers Squibb Co. 
• CBC Comprehensive Biomarker Center GmbH
• Cobalt Technologies
• Evolva Holdings SA
• Exxon Mobil Corp. 
• GeneWorks Pty Ltd.
• Genomatica Inc.
• Gevo Inc.
• Ginkgo Bioworks 
• Green Biologics Ltd.
• New England Biolabs Inc.
• OriGene Technologies Inc.
• REG Life Sciences LLC
• Royal DSM
• Synthorx Inc.

Key Market Driver
• Increased R&D in Synthetic Biology
• For a full, detailed list, view our report.

Key Market Challenge
• Lack of Modularized Biological Parts
• For a full, detailed list, view our report.

Key Market Trend
• Growing Demand for GM Crops
• For a full, detailed list, view our report.

Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?


Companies Mentioned

Amyris Inc., E. I. du Pont de Nemours and Co., Thermo Fisher Scientific Inc., Synthetic Genomics Inc., Algenol Biofuels Inc., ATG:biosynthetics GmbH, Bayer AG, Bioneer Corp., Biosearch Technologies Inc., Bristol-Myers Squibb Co., CBC Comprehensive Biomarker Center GmbH, Cobalt Technologies, Evolva Holdings SA, Exxon Mobil Corp., GeneWorks Pty Ltd., Genomatica Inc., Gevo Inc., Ginkgo Bioworks, Green Biologics Ltd., New England Biolabs Inc., OriGene Technologies Inc., REG Life Sciences LLC, Royal DSM, Synthorx Inc.

To view the table of contents and know more details please visit Global Synthetic Biology Market 2014-2018.

Page views: 41